Beijing Lu
Director/Miembro de la Junta en TEYI PHARMACEUTICAL GROUP CO.,LTD .
Origen de la red de primer grado Beijing Lu.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Sun Yat-Sen University
168
| College/University | Other Consumer Services | 168 |
| Public Company | Pharmaceuticals: Major | 14 | |
| Public Company | Chemicals: Specialty | 13 | |
Hao Cheng Holding Ltd.
 Hao Cheng Holding Ltd. Electronic Production EquipmentElectronic Technology Hao Cheng Holding Ltd. engages in the provision of smartphone printed circuit board assembly solutions. It also manufactures electronic smart devices. It operates through the following segments: Development, Design, Production, Management, and Sales of PCBA for Smartphones; Original Design Manufacturer of Smartphones; Development, Design, Production, Management, and Sales of Electronic Devices; and Sales of Materials and Components. The company was founded on April 4, 2018 and is headquartered in Shenzhen, China.
9
| Private Company | Electronic Production Equipment | 9 |
Grandall Law Firm
 Grandall Law Firm Miscellaneous Commercial ServicesCommercial Services Grandall Law Firm is a law firm based in China. The Chinese company provides legal services to clients in various industries. Grandall Law Firm was founded by Chun Li.
5
| Private Company | Miscellaneous Commercial Services | 5 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Beijing Lu a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| Michigan State University | College/University | Doctorate Degree | |
| George Washington University | College/University | Doctorate Degree | |
Moody's Investors Service, Inc.
 Moody's Investors Service, Inc. Insurance Brokers/ServicesFinance Moody's Investors Service, Inc. is a credit rating and investment research firm headquartered in New York City. They are a subsidiary of Moody's Corp. (NYSE: MCO). The firm performs international financial research and analysis on commercial and government entities and provides a variety of analytic tools for assessing credit risk. Their clients include creditors, investment banks and commercial banks. | Insurance Brokers/Services | Analyst-Fixed Income | |
| Wuhan University | College/University | Undergraduate Degree Undergraduate Degree | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Graduate Degree | |
| Jinan University | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| Jilin University | College/University | Graduate Degree | |
| Dalian University of Technology | College/University | Undergraduate Degree | |
| Xiamen University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Renmin University of China | College/University | Doctorate Degree Undergraduate Degree | |
| The Hong Kong University of Science & Technology | College/University | Graduate Degree Doctorate Degree | |
| Beijing Normal University | College/University | Doctorate Degree Undergraduate Degree | |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Chinese Institute of Certified Public Accountants
 The Chinese Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The Chinese Institute of Certified Public Accountants operates as an accounting organization. The private company is based in Beijing, China. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| East China University of Political Science & Law | College/University | Undergraduate Degree Undergraduate Degree | |
| Xiangtan University | College/University | Undergraduate Degree | |
| GUANGZHOU BAIYUN ELECTRIC EQUIPMENT CO., LTD. | Electrical Products | Director/Board Member Director/Board Member | |
| SHENZHEN ZOWEE TECHNOLOGY CO., LTD. | Electronic Production Equipment | Director of Finance/CFO | |
| Guangdong Radio & TV University | College/University | Undergraduate Degree | |
| Open University of China | College/University | Undergraduate Degree | |
| BYHEALTH CO., LTD | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| The Chinese Biopharmaceutical Association | President | ||
| Lingnan (University) College, Sun Yat Sen University | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Biotechnology | Chief Executive Officer | |
Guangdong Hongtai Technology (Holdings) Co. Ltd.
 Guangdong Hongtai Technology (Holdings) Co. Ltd. Metal FabricationProducer Manufacturing Guangdong Hongtai Technology (Holdings) Co. Ltd. is a Chinese company that manufactures die casting parts for the automobile, escalator, and telecommunications industries. The private company is based in Guangdong, China. | Metal Fabrication | President | |
| XINJI SHAXI GROUP CO., LTD | Real Estate Development | Director/Board Member | |
| JIUJIUWANG FOOD INTERNATIONAL LIMITED | Food: Specialty/Candy | Director of Finance/CFO | |
| POLY PROPERTY SERVICES CO., LTD. | Real Estate Development | Corporate Secretary Chief Executive Officer | |
| Shanghai Hao Cheng Communication Technology Co., Ltd. | Chairman Chief Executive Officer | ||
| Shenzhen Discovy Digital Technology Co., Ltd. | Chief Executive Officer Chief Administrative Officer | ||
| Shenzhen Municipal Jurun Communication Technology Co. Ltd. | Director of Finance/CFO | ||
| Shenzhen Municipal Xinzhuoyue Communication Technology | Director of Finance/CFO | ||
| Shenzhen Platinum Oxidation Board Industry Technology Co. Ltd. | Director of Finance/CFO | ||
| Shenzhen Xindiheng Communication Technology Co. Ltd. | Chief Administrative Officer | ||
Foshan Water & Environmental Protection Co., Ltd.
 Foshan Water & Environmental Protection Co., Ltd. Water UtilitiesUtilities Foshan Water & Environmental Protection Co., Ltd. is an investment holding company. The company is engaged in providing integrated water environment protection services in Foshan and Guangdong. It operates through the following segments: Running Water Supply, Wastewater & Sludge Treatment and Engineering & Construction. The Running Water Supply segment provides running water supply services. It constructs and operates running water supply projects and provides O&M services to running water supply facilities. The Wastewater and Sludge Treatment segment treats and discharges wastewater and sludge in compliance with applicable national and local standards. The Engineering & Construction segment engineers and constructs municipal water supply and drainage infrastructure, environment protection infrastructure, public roadways and municipal landscaping ancillary facilities. The company was founded on January 1, 1964 and is headquartered in Foshan, China. | Water Utilities | Director/Board Member Corporate Officer/Principal | |
| Zhaoqing Gaoyao Hongyi Information Co. Ltd. | Director/Board Member | ||
| Fujian Jiujiuwang Food Industry Co. Ltd. | Comptroller/Controller/Auditor | ||
China Construction Bank (Foshan Branch)
 China Construction Bank (Foshan Branch) Regional BanksFinance China Construction Bank (Foshan Branch) provides banking services. The private company is based in Foshan, China. | Regional Banks | Corporate Officer/Principal | |
| YATSEN HOLDING LIMITED | Specialty Stores | Chief Executive Officer Founder | |
| Ascentage Pharma Group, Inc. | Director/Board Member | ||
| Jiangsu Ascentage Pharma Pty Ltd. | Director/Board Member | ||
| Ascentage International Ltd. | Director/Board Member | ||
| Shanghai Yasheng Pharmaceutical Technology Co., Ltd. | Director/Board Member | ||
| Xiamen Juxin Investment Co. Ltd. | Director of Finance/CFO | ||
Ascentage Pharma Suzhou Co Ltd
 Ascentage Pharma Suzhou Co Ltd Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Suzhou Ascentage Pharma Co., Ltd. is a pharmaceutical company. Suzhou Ascentage Pharma Co., Ltd. is based in Suzhou, China. The Chinese company was founded in 2016 by Guang Feng Wang. The CEO is Da Jan Yang. | Pharmaceuticals: Major | Chief Executive Officer | |
Ascentage Pharma Group Corp. Ltd.
 Ascentage Pharma Group Corp. Ltd. Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Ascentage Pharma Group Corp. Ltd. is a Chinese biopharmaceutical company. The company is based in Hong Kong, Hong Kong. The company was founded by Shao Meng Wang. | Pharmaceuticals: Major | Director/Board Member | |
| Nanchang Hangkong University | College/University | Undergraduate Degree Undergraduate Degree |
Estadísticas
Internacional
| China | 36 |
| Estados Unidos | 9 |
| Hong-Kong | 4 |
| Islas Caimán | 3 |
| Singapur | 2 |
Sectorial
| Consumer Services | 20 |
| Health Technology | 6 |
| Finance | 5 |
| Producer Manufacturing | 3 |
| Commercial Services | 2 |
Operativa
| Director/Board Member | 184 |
| Independent Dir/Board Member | 102 |
| Corporate Officer/Principal | 84 |
| Undergraduate Degree | 62 |
| Graduate Degree | 30 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Hai Yan Zou | 24 |
| Rui Lu | 16 |
| Xi Wang | 13 |
| Danjun Lin | 12 |
| Da Jan Yang | 12 |
| Zhi Bin Chen | 11 |
| Xiao Yao Xie | 10 |
| Biao Yang | 10 |
| Jian Hua Liu | 10 |
| Chun Yip Pang | 8 |
| Xingshi Chen | 8 |
| Yuejun Li | 8 |
| Dan Wang | 8 |
| Sheng Lan Li | 8 |
| Wen Cheng | 8 |
- Bolsa de valores
- Insiders
- Beijing Lu
- Conexiones Empresas
